Previous studies have shown that HPV has the potential to elevate the levels of cyclooxygenase (COX)-2 and prostaglandin (PG) E2, triggering the COX-PG pathway in cervical cancer, which is considered the primary driver of HPV-induced inflammation [49]. This evidence concerns the gene JUP and cervical carcinoma.